| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2025―Feb―26 |
Randomized, waitlist-controlled trial of Cordyceps sinensis mycelium culture extract (Cs4) for long COVID patients in Hong Kong |
Yuanyuan Chen, Guang Chen, Cheng Zhang, Guoyi Tang, Yautuen Chan, Ning Wang, Yibin Feng |
| 2 |
[GO] |
2024―Oct―01 |
High-throughput modular click chemistry synthesis of catechol derivatives as covalent inhibitors of SARS-CoV-2 3CLpro |
Feng Wang, Tiancheng Ma, Donglan Liu, Yixin Cen, Shidong Deng, Lu Zhang, et al. (+5) Guoqiang Lin, Dingding Gao, Jincun Zhao, Jiajia Dong, Ping Tian |
| 3 |
[GO] |
2023―Sep―13 |
An intrinsic connection between COVID-19 and aging |
Jingchao Wang, Jonathan Wei, Fabin Dang, Hiroyuki Inuzuka |
| 4 |
[GO] |
2023―Jul―07 |
1,7-Bis(4-hydroxyphenyl)-1,4,6-heptatrien-3-one inhibits SARS-CoV-2 by targeting the nucleocapsid protein |
Yang Liu, Kuiru Sa, Wei Xu, Yongkang Chen, Jing Liang, Peng Zou, Lixia Chen |
| 5 |
[GO] |
2023―Jun―27 |
Efgartigimod, an FcRn antagonist, as a potential treatment for post COVID-19 syndrome |
Sandra E. Reznik, Amit K. Tiwari, Charles R. Ashby |
| 6 |
[GO] |
2022―Aug―03 |
Establishment of a protein thermal shift chip (PTSC) for COVID-19 and exploration of the future of protein chips in pharmacology |
Peng Chen, Zhao Cui, Caifeng Li, Shiwen Deng, Hongjun Yang |
| 7 |
[GO] |
2022―Apr―07 |
Prognosis and treatment of complications associated with COVID-19: a systematic review and meta-analysis |
Xudong Xie, Liangcong Hu, Hang Xue, Yuan Xiong, Adriana C. Panayi, Ze Lin, et al. (+5) Lang Chen, Chenchen Yan, Wu Zhou, Bobin Mi, Guohui Liu |
| 8 |
[GO] |
2022―Mar―18 |
Regulatory lessons from China’s COVID-19 vaccines development and approval policies |
Jingshu Yang, Yue Yang |
|
